Spyre Therapeutics

SYRE · NASDAQ

$91.40+$6.68 (+7.88%)TodayMarket closed ·
Prev close $84.72

Who owns SYRE

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 53.2% of SYRE’s shares.

  • Fidelity Management & Research Company LLC14.9%
  • BlackRock Institutional Trust Company, N.A.6.6%
  • Perceptive Advisors LLC5.0%
  • RTW Investments L.P.4.9%
  • Next 6 largest institutions21.9%
  • All other shareholders46.8%
Top institutional holders of SYRE
HolderShares% of shares
Fidelity Management & Research Company LLC12.92M14.87%
BlackRock Institutional Trust Company, N.A.5.72M6.59%
Perceptive Advisors LLC4.32M4.97%
RTW Investments L.P.4.25M4.90%
Paradigm BioCapital Advisors LP3.84M4.42%
Vanguard Capital Management, LLC3.45M3.97%
State Street Investment Management (US)3.06M3.52%
VR Adviser, LLC2.99M3.44%
T. Rowe Price Associates, Inc.2.85M3.29%
Driehaus Capital Management, LLC2.80M3.22%

Largest mutual fund holders

Top mutual fund holders of SYRE
HolderShares% of shares
Fidelity Growth Company Fund2.67M3.07%
American Funds SMALLCAP World Fund2.56M2.95%
Vanguard Total Stock Market Index Fund2.49M2.87%
iShares Russell 2000 ETF1.92M2.21%
State Street SPDR S&P Biotech ETF1.40M1.61%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $438.30M (78 trades) of SYRE on the open market, with no buys.

Latest SYRE insider transactions
InsiderTypeSharesValue
King-Jones HeidyOption exercise28.93K—
King-Jones HeidySale2.60K$243.00K
King-Jones HeidySale2.10K$194.67K
King-Jones HeidySale7.23K$660.28K
King-Jones HeidySale16.61K$1.50M
King-Jones HeidySale400$35.70K
King-Jones HeidyOption exercise28.93K$419.53K
Turtle CameronSale100$9.39K
Turtle CameronSale4.99K$465.92K
Turtle CameronSale3.99K$368.22K

Short interest

Settled Sep 30, 2026

Shares short
12.84M
Days to cover
8.89
% of shares outstanding
14.79%
Average daily volume
1.44M
Change since last report
+5.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.